Hepatic cavernous hemangioma developed in non-small cell lung cancer patients after receiving Camrelizumab treatment: two case reports

PURPOSE: To report two cases of hepatic cavernous hemangioma, a rare complication, in patients with locally advanced and advanced non-squamous non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors. Additionally, to share clinical experiences related to the management of this condition. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yonglong, Xu, Jinpeng, Zhuang, Dunmin, Dong, Lina, Sun, Yang, Zhao, Lin, Xiao, Wenjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435320/
https://www.ncbi.nlm.nih.gov/pubmed/37601678
http://dx.doi.org/10.3389/fonc.2023.1221309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435320/
https://www.ncbi.nlm.nih.gov/pubmed/37601678
http://dx.doi.org/10.3389/fonc.2023.1221309

Ejemplares similares